| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00240-003-0383-5 |
| P698 | PubMed publication ID | 15250102 |
| P2093 | author name string | Thomas Knoll | |
| Daniel Thomas | |||
| Maurice Stephan Michel | |||
| Peter Alken | |||
| Lutz Trojan | |||
| Rainer Grobholz | |||
| P2860 | cites work | Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma | Q73840540 |
| Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate | Q77359737 | ||
| Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas | Q77364528 | ||
| Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer | Q77827950 | ||
| Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1 | Q77932331 | ||
| The role of angiogenesis in prostate and other urologic cancers: a review | Q33955367 | ||
| Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs | Q34178829 | ||
| Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
| Anticancer therapy with angiogenesis inhibitors. | Q34624211 | ||
| Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines | Q40886167 | ||
| Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants | Q41140250 | ||
| Angiogenic molecules and cancer metastasis. | Q41758930 | ||
| Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. | Q42475524 | ||
| Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates | Q42477282 | ||
| Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue | Q42507121 | ||
| Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. | Q42805196 | ||
| Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro | Q43803845 | ||
| Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression | Q44248450 | ||
| Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging | Q69737582 | ||
| Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate | Q73048634 | ||
| Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer | Q73179856 | ||
| Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate | Q73409361 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| neovascularization | Q1281049 | ||
| P304 | page(s) | 97-103 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Urological Research | Q15746542 |
| P1476 | title | Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer | |
| P478 | volume | 32 |
| Q42484966 | Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma |
| Q41142802 | Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women |
| Q96229729 | Conditioned medium produced by fibroblasts cultured in low oxygen pressure allows the formation of highly structured capillary-like networks in fibrin gels |
| Q40175929 | Effect of obese and lean Zucker rat sera on human and rat prostate cancer cells: implications in obesity-related prostate tumor biology |
| Q57093730 | Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma |
| Q42466619 | Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis |
| Q36259629 | Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice |
| Q37070488 | Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans |
| Q34254356 | Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? |
| Q36417743 | Mechanisms of disease: angiogenesis in urologic malignancies. |
| Q79443116 | Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue |
| Q36582853 | New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells |
| Q51062853 | Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression. |
| Q37476043 | Prostate cancer: the need for biomarkers and new therapeutic targets |
| Q36729107 | Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion. |
| Q36150842 | Targeted therapies for prostate cancer |
| Q51328396 | The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells. |
| Q53358684 | The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma. |
Search more.